Low Utilization of Statins for Primary Prevention of ASCVD

Also, usage was lowest in Blacks and Hispanics, who have higher ASCVD risk than whites.

Stark disparities in atherosclerotic cardiovascular disease (ASCVD) exist in the U.S., with a higher rate among Black versus white adults. In the current national guidelines, 10-year estimated ASCVD risk is used for recommendations about statin initiation, and Black race is included as a variable resulting in higher risk estimation and likelihood of recommendation for statin therapy.

To examine trends in prevalence of statin use for primary prevention by race and ethnicity and 10-year ASCVD risk, researchers conducted a cross-sectional analysis of nationally representative U.S. survey data from respondents aged 40 to 75 years without ASCVD, diabetes, or elevated low-density lipoprotein cholesterol (LDL) level. Mean age was 62 years, 38% were…

Reviewing Author

Karol E. Watson, MD, PhD, FACC

Disclosures

Consultant/Advisory BoardBoehringer Ingelheim; Amgen; Novartis; Lilly; Amarin

Speaker’s BureauBoehringer Ingelheim

Grant/Research SupportNIH

Editorial BoardsCirculation (Associate Editor)